- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04382287
Comparison of Remineralisation Efficacy of MI PASTE Plus® and REMIN PRO® for White Spot Lesions in Primary Teeth
Comparison of Clinical Efficacy of MI PASTE Plus® and REMIN PRO® for the Remineralisation of Enamel White Spot Lesions in Primary Teeth
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective: To evaluate and compare the clinical efficacy of Remin Pro® and MI Paste Plus® for the remineralisation of white spot lesions (WSL) on the enamel of primary teeth.
Methods: The selected design for this study was a randomised double-blind clinical trial based on CONSORT guidelines. Patients with at least one upper anterior primary tooth with a WSL on the enamel surface, with units of fluorescence (UF) ranged from 11-20 (evaluated with DIAGNOdent) were included in the study. Patients were randomly assigned to receive either the twice-daily at-home topical application of Remin Pro® or MI Paste Plus® (both as experimental pastes) or Colgate Total® (as control paste). The degree of remineralisation was quantified by the change in the number of UF from the baseline evaluation and at days 10 and 21. The difference between groups was statistically evaluated using ANCOVA and ANOVA techniques.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
San Luis Potosi, Mexico, 78990
- Faculty of Dentistry, Universidad Autónoma de san Luis Potosi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Young paediatric patients with at least one upper anterior primary tooth exhibiting one or several WSL on the smooth enamel surface.
- Attending the Paediatric Dentistry Postgraduate Program's Clinic
- Enamel lesions with units of fluorescence (UF) ranging from 11-20 as determined by DIAGNOdent
- Signed Informed Consent
Exclusion Criteria:
- History of hypersensitivity to any of the compounds of the pastes
- Enamel hypoplasia
- Compromising systemic diseases
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: REMIN paste
The child's parents or caregivers were provided with printed instructions for applying the paste at home.
The indicated procedure was as follows: application of the remineralisation agent was limited to the tooth's vestibular surface twice a day, after conventional toothbrushing (both in the morning and at night).
The maximal amount of paste to be applied was equal to a pea-sized portion (one finger) per surface.
The paste was applied using the parent or caregiver's finger across the WSL surface.
After the application of the paste, patients were asked to avoid eating or drinking anything for the next hour.
|
Te toothastes were applied at home twice a day over the six anterior upper primary teeth
|
Experimental: MI PASTE PLUS
The child's parents or caregivers were provided with printed instructions for applying the paste at home.
The indicated procedure was as follows: application of the remineralisation agent was limited to the tooth's vestibular surface twice a day, after conventional toothbrushing (both in the morning and at night).
The maximal amount of paste to be applied was equal to a pea-sized portion (one finger) per surface.
The paste was applied using the parent or caregiver's finger across the WSL surface.
After the application of the paste, patients were asked to avoid eating or drinking anything for the next hour.
|
Te toothastes were applied at home twice a day over the six anterior upper primary teeth
|
Active Comparator: COLGATE Total
The child's parents or caregivers were provided with printed instructions for applying the paste at home.
The indicated procedure was as follows: application of the remineralisation agent was limited to the tooth's vestibular surface twice a day, after conventional toothbrushing (both in the morning and at night).
The maximal amount of paste to be applied was equal to a pea-sized portion (one finger) per surface.
The paste was applied using the parent or caregiver's finger across the WSL surface.
After the application of the paste, patients were asked to avoid eating or drinking anything for the next hour.
|
Te toothastes were applied at home twice a day over the six anterior upper primary teeth
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Enamel remineralisation degree
Time Frame: 10 days
|
The remineralisation degree was quantified by the change in UF from the baseline (0 day) up to day 10 of twice-daily applications, by evaluation on the 10th day.
|
10 days
|
Enamel remineralisation degree
Time Frame: 21 days
|
The remineralisation degree was quantified by the change in UF from the 10th day up to the 21st day, after twice-daily applications
|
21 days
|
Collaborators and Investigators
Investigators
- Study Director: Amaury Pozos-Guillén, PhD, San Luis Potosi University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- JRangel
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on White Spot Lesion
-
Al-Azhar UniversityEnrolling by invitation
-
Texas A&M UniversityCompletedWhite Spot LesionUnited States
-
Izmir Katip Celebi UniversityCompletedRemineralization | White Spot LesionTurkey
-
Ivoclar Vivadent AGIuliu Hatieganu University of Medicine and PharmacyActive, not recruiting
-
Ondokuz Mayıs UniversityCompletedWhite Spot LesionTurkey
-
Ivoclar Vivadent AGIstanbul Medipol University HospitalActive, not recruiting
-
University of PaviaCompleted
-
Benha UniversityCompleted
-
Imam Abdulrahman Bin Faisal UniversityUnknownWhite Spot LesionSaudi Arabia
Clinical Trials on Remin Pro® and MI Paste Plus®
-
Izmir Katip Celebi UniversityCompletedRemineralization | White Spot LesionTurkey
-
Imam Abdulrahman Bin Faisal UniversityUnknownWhite Spot LesionSaudi Arabia
-
Ain Shams UniversityCompleted
-
pfm medical agAix Scientifics; Crolll Gmbh; Bayes GmbHCompletedCystocele | Uterine ProlapseGermany
-
Suez Canal UniversityCompleted
-
Suez Canal UniversityCompleted
-
Azienda Socio Sanitaria Territoriale degli Spedali...Completed
-
Abbott Medical DevicesCompletedPeripheral Vascular Disease | Peripheral Artery DiseaseUnited States
-
University of ZurichBorrow FoundationCompletedErosion ProtectionSwitzerland
-
Becton, Dickinson and CompanyWithdrawnDiabetes Mellitus, Type 1